Role of sentinel node biopsy in patients having neoadjuvant chemotherapy

European Journal of Surgical Oncology

Volumn 36, Issue 6, 2010, Pages 511-513

  Dixon, J M ^a,b   Cody III, H S ^c,d  

^a Breakthrough Research Unit   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BODY MASS; BREAST; CANCER PATIENT; CANCER STAGING; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURGEON; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; META-ANALYSIS AS TOPIC; NEOADJUVANT THERAPY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 77953134604     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.04.009     Document Type: Editorial

References (32)

1. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. Journal of the National Cancer Institute 98 9 (2006) 599-609
2. Fringuelli F.M., Lima G., Bottini A., Aguggini S., Allevia G., and Bonardi S. Lymphoscintigraphy: the experience of the Cremona breast unit. Available from:. http://2004.bucremona.org/index.aspx?m=53&did=25
3. Xing Y., Foy M., Cox D.D., Kuerer H.M., Hunt K.K., and Cormier J.N. Meta-analysis of sentinel node biopsy after preoperative chemotherapy in patients with breast cancer. British Journal of Surgery 93 (2006) 539-546
4. Fraile M., Rull M., Julian F.J., et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Annals of Oncology 11 (2000) 701-705
5. Miltenburg D.M., Miller C., Karamlou T.B., and Brunicardi F.C. Meta-analysis of sentinel lymph node biopsy in breast cancer. Journal of Surgical Research 84 (1999) 138-142
6. Kim T., Agboola O., and Lyman G.H. Lymphatic mapping and sentinel lymph node sampling in breast cancer: a meta-analysis. 2002 ASCO Annual Meeting Proceedings, Orlando, Fl, 2002. Available from:. http://www.asco.org.uk/ac/1, 1003,_12-002643-00-18-0016-00_19-00139, oo.asp
7. van Deurzen C.H.M., Vriens B.E.P.J., Tjan-Heijnen V.C.G., et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. European Journal of Cancer 45 (2009) 3124-3130
8. Kang S.H., Kim S.K., Kwon Y., et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World Journal of Surgery 28 (2004) 1019-1024
9. Lee S., Kim E.Y., Kang S.H., et al. Sentinel node identification rate but not accuracy is significantly decreased after preoperative chemotherapy in axillary node positive breast cancer patients. Breast Cancer Research and Treatment 102 (2007) 283-288
10. Jones J.L., Zabicki K., Christina R.L., et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. American Journal of Surgery 190 (2005) 517-520
11. Julian T.B., Dusi D., and Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. American Journal of Surgery 184 (2002) 315-317
12. Breslin T.M., Cohen L., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. Journal of Clinical Oncology 18 (2000) 3480-3486
13. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National surgical adjuvant breast and bowel project B-18. Journal of Clinical Oncology 15 (1997) 2483-2493
14. Shimazu K., Tamaki Y., Taguchi T., Akazawa K., Unoue T., and Noguchi S. Sentinel node lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 100 (2004) 2555-2561
15. Stearns V., Ewing C.A., Slack R., Penannen M.F., Hayes D.F., and Tsangaris T.N. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of Surgical Oncology 9 (2002) 235-242
16. Balch G.C., Mithani S.K., Richards K.R., Beauchamp R.D., and Kelley M.C. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Annals of Surgical Oncology 10 (2003) 616-621
17. Schwartz G.F., and Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast Journal 9 (2003) 374-379
18. Reitsamer R., Peintinger F., Rettenbacher L., and Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Journal of Surgical Oncology 84 (2003) 63-67
19. Nason K.S., Anderson B., Byrd D.R., et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 (2000) 2187-2194
20. Newman E.A., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node positive breast cancer at presentation. Annals of Surgical Oncology 14 (2007) 2946-2952
21. Lang J.E., Esserman L.J., Ewing C.A., et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. Journal of the American College of Surgeons 199 (2004) 856-862
22. Tausch C., Konstantiniuk P., Kugler F., et al., Austrian Sentinel Node Study Group. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Annals of Surgical Oncology 15 (2006) 3378-3383
23. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. Journal of Clinical Oncology 23 (2005) 2694-2702
24. Shen J., Gilcrease M.Z., Babiera G.V., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109 (2007) 1255-1263
25. Gimbergues P., Abrial C., Durando X., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Annals of Surgical Oncology 15 (2008) 1316-1321
26. Hino M., Sano M., Sato N., and Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surgery Today 38 (2008) 585-591
27. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer 14 (2007) 10-15
28. Sabel M.S., Schott A.F., Kleer C.G., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. American Journal of Surgery 186 (2003) 102-105
29. Straver M.E., Rutgers E.J.T., Russell N.S., et al. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. European Journal of Cancer 45 (2009) 2284-2292
30. Krag D.N., Anderson S.J., Julian T.B., et al., for the National Surgical Adjuvant Breast and Bowel Project (NSABP). Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncology 8 (2007) 881-888
31. Kuehn T., Bauerfeind I., Fehm T., et al. SENTinel node biopsy before or after NeoAdjuvant systemic treatment: the German SENTINA trial. Cancer Research 69 Suppl. 2 (2009). Post No: 1008. Presented at 32nd San Antonio Breast Cancer Conference, December 2009. Available from: http://www.posters2view.com/sabcs09/lookup_view.php?word=Kuehn&where =authors&return=%2Fsabcs09%2Fauthorindex.php%3Fnum%3D10%26page%3D5%2 6start%3D156%26stop%3D39
32. Dominici L.S., Negron Gonzalez V.M., Buzdar A.U., et al. Eradication of axillary lymph node metastases occurs in 74% of patients receiving neoadjuvant chemotherapy with concurrent trastuzumab for HER2 positive breast cancer. Cancer Research 69 Suppl. 2 (2009). Poster No: 1086 Presented at 32nd San Antonio Breast Cancer Conference, December 2009. Available from: http://www.posters2view.com/sabcs09/lookup_view.php?word=Dominici&wh ere=authors&return=%2Fsabcs09%2Fauthorindex.php%3Fnum%3D3%26page%3D5 %26start%3D156%26stop%3D39